M. Tometsko

发表

Functional Characterization of the Human Interleukin-15 Receptor αChain and Close Linkage of IL15RA and IL2RA Genes (*)

N. Copeland, D. Gilbert, N. Jenkins, 1995, The Journal of Biological Chemistry.

A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function*

W. Dougall, C. Sutherland, D. Cosman, 2002, The Journal of Biological Chemistry.

The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily*

W. Dougall, D. Cosman, Dirk M. Anderson, 1998, The Journal of Biological Chemistry.

RANK is essential for osteoclast and lymph node development.

W. Dougall, P. Morrissey, J. Peschon, 1999, Genes & development.

Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and Tolerability.

D. Rock, Brooke M. Rock, W. Fanslow, 2016, Molecular pharmaceutics.

Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α*

S. Akira, J. Derry, K. Takeda, 2004, Journal of Biological Chemistry.

RANK and RANK ligand expression in primary human osteosarcoma

D. Branstetter, W. Dougall, A. Jacob, 2015, Journal of bone oncology.

Microsoft Word-28451548-file00.docx

Brooke M. Rock, W. Fanslow, K. J. Hamblett, 2015 .

Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.

S. Akira, J. Derry, K. Takeda, 2004, The Journal of biological chemistry.

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

R. Dubose, W. Dougall, D. Cosman, 1997, Nature.

SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm.

D. Rock, Brooke M. Rock, W. Fanslow, 2015, Cancer research.

RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.

F. Climent, D. Branstetter, W. Dougall, 2012, Cancer research.

RANK expression on breast cancer cells promotes skeletal metastasis

W. Dougall, Robert E. Miller, Jon C Jones, 2013, Clinical & Experimental Metastasis.

RANK expression on breast cancer cells promotes skeletal metastasis

W. Dougall, Robert E. Miller, Jon C Jones, 2014, Clinical & Experimental Metastasis.

Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker

D. Rock, Brooke M. Rock, W. Fanslow, 2015, Drug Metabolism and Disposition.

Comprehensive Immune Profiling from Peripheral Blood and Bone Marrow in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Reflects Differences in Immune Subsets and Activation Status

F. Schmitz, V. Komashko, A. Agarwal, 2018, Blood.

Immune Microenvironment Analysis of Bone Marrow By Mass Cytometry and RNA Sequencing in Multiple Myeloma Patients Treated with Daratumumab and Durvalumab

J. Gribben, J. Cavenagh, E. Whalen, 2018, Blood.

Immune Profile of Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM) Treated with Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) + Daratumumab (DARA) in the Second Line Immediately after Lenalidomide (LEN)

D. Reece, A. Agarwal, G. Schiller, 2017 .

RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non–Small-Cell Lung Cancer Bone Metastases

W. Dougall, Robert E. Miller, Jon C Jones, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non – Small-Cell Lung Cancer Bone Metastases

W. Dougall, Robert E. Miller, Jon C Jones, 2014 .